Download in electronic PDF format for $25



Search the Complete Journal Archives

Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes

Author(s):  Anderson Collin R,Halford Zachery,MacKay Mark

Issue:  Jul/Aug 2015 - Volume 19, Number 4
View All Articles in Issue

Abstract:  Chemotherapy-induced nausea and vomiting is problematic for many patients undergoing chemotherapy. Multiple-drug treatments have been developed to mitigate chemotherapy induced nausea and vomiting. A patient-controlled infusion of diphenhydramine hydrochloride, lorazepam, and dexamethasone sodium phosphate has been studied in patients who are refractory to first-line therapy. Unfortunately, the physical and chemical compatibility of this three-drug combination is not available in the published literature. Chemical compatibility was evaluated using high-performance liquid chromatography with ultraviolet detection. Visual observation was employed to detect change in color, clarity, or gas evolution. Turbidity and pH measurements were performed in conjunction with visual observation at hours 0, 24, and 48. Results showed that diphenhydramine hydrochloride 4 mg/mL, lorazepam 0.16 mg/mL, and dexamethasone sodium phosphate 0.27 mg/mL in 0.9% sodium chloride stored in polypropylene syringes were compatible, and components retained greater than 95% of their original concentration over 48 hours when stored at room temperature.

Related Keywords: Collin R. Anderson, PharmD, PhD, BCPS, Zachery Halford, PharmD, BCOP, Mark MacKay, BS Pharm, diphenhydramine hydrochloride, lorazepam, dexamethasone sodium phosphate, chemotherapy-induced nausea and vomiting, CINV, cancer, drug combination, physical compatibility, chemical compatibility, emesis, antiemesis, antiemetic therapy, BAD pump, patient-controlled infusion, compounded sterile preparations, stability, isotonic normal saline solution

Related Categories: CANCER AND AIDS, EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, ADVERSE DRUG EVENTS, STORAGE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Anderson Collin R, Halford Zachery, MacKay Mark Jul/Aug 2015 344-347 Buy
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Wu George, Yeung Stanley, Chen Frank Jan/Feb 2017 66-75 Buy
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr Mar/Apr 2004 126 Buy
Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael Sep/Oct 2016 435-437 Buy
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank Jan/Feb 2017 76-82 Buy
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr Nov/Dec 2015 508 Buy
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Moon Richard B Mar/Apr 2006 95-98 Buy
Transdermals: The Skin as Part of a Drug Delivery System Allen Loyd V Jr Jul/Aug 2011 308-315 Buy
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A Nov/Dec 2007 520-524 Buy
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Trissel Lawrence A, Zhang Yanping Sep/Oct 2004 398-403 Buy